Dynamics of HCV viremia during early HCV infection: Implications for minipool (MP) vs individual donation (ID) nucleic acid amplification testing (NAT)

被引：0
|
作者：
Busch, MP
Giachetti, C
Conrad, A
Gallarda, J
Mimms, LT
Peddada, L
Charles, H
Raia, S
Fiebig, EW
Wright, D
机构：
[1] GenProbe Inc, San Diego, CA USA
[2] Blood Ctr Pacific, San Francisco, CA USA
[3] Roche Mol Syst Inc, Pleasanton, CA USA
[4] Alpha Therapeut, Los Angeles, CA USA
[5] BioClin Partners, Franklin, MA USA
[6] Univ Calif San Francisco, San Francisco Gen Hosp, Med Ctr, San Francisco, CA USA
[7] Westat Inc, San Luis Obispo, CA USA
[8] Natl Inst Genet, Los Angeles, CA USA
来源：
TRANSFUSION | 2000年 / 40卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：25S / 26S
页数：2
相关论文
共 30 条
  • [21] An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NAT
    Faddy, Helen M.
    Osiowy, Carla
    Custer, Brian
    Busch, Michael
    Stramer, Susan L.
    Dean, Melinda M.
    Acutt, Jessika
    Viennet, Elvina
    van de Laar, Thijs
    Tsoi, Wai-Chiu
    Styles, Claire
    Kiely, Phil
    Margaritis, Angelo
    Kwon, So-Yong
    Qiu, Yan
    Deng, Xuelian
    Lewin, Antoine
    Jorgensen, Signe Winther
    Erikstrup, Christian
    Juhl, David
    Sauleda, Silvia
    Camacho Rodriguez, Bernardo Armando
    Soto Coral, Lisbeth Jennifer Catherine
    Gaviria Garcia, Paula Andrea
    Oota, Sineenart
    O'Brien, Sheila F.
    Wendel, Silvano
    Castro, Emma
    Navarro Perez, Laura
    Harvala, Heli
    Davison, Katy
    Reynolds, Claire
    Jarvis, Lisa
    Grabarczyk, Piotr
    Kopacz, Aneta
    Letowska, Magdalena
    O'Flaherty, Niamh
    Young, Fiona
    Williams, Padraig
    Burke, Lisa
    Chua, Sze Sze
    Muylaert, An
    Page, Isabel
    Jones, Ann
    Niederhauser, Christoph
    Vermeulen, Marion
    Laperche, Syria
    Gallian, Pierre
    Satake, Masahiro
    Addas-Carvalho, Marcelo
    VOX SANGUINIS, 2024, 119 (07) : 745 - 751
  • [22] Sensitivity of 1st and 2nd generation HCV antigen assays versus nucleic acid testing (NAT) for detection of ramp-up phase of HCV infection
    Busch, MP
    Wright, DJ
    Hirschkorn, DF
    Baggett, D
    Maret, S
    Lee, SR
    TRANSFUSION, 2001, 41 (09) : 3S - 3S
  • [23] Implementation of an HIV-1/HCV nucleic acid testing (NAT) on single donation samples in a 45,000 donations a year Blood Center.
    González, R
    Barea, L
    Bueno, J
    Castro, E
    TRANSFUSION, 2001, 41 (09) : 83S - 84S
  • [24] Cost-effectiveness (CE) of screening donated blood with minipool nucleic acid testing (NAT) for hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV)
    Grima, DT
    Marshall, D
    Weinstein, M
    Wong, JB
    Kleinman, S
    AuBuchon, J
    VALUE IN HEALTH, 2002, 5 (06) : 446 - 446
  • [25] The first large-scale nucleic acid amplification testing (NAT) of donated blood using multiplex reagent for simultaneous detection of HBV, HCV, and HIV-1 and significance of NAT for HBV
    Ohnuma, H
    Tanaka, T
    Yoshikawa, A
    Murokawa, H
    Minegishi, K
    Yamanaka, R
    Iizuka, HY
    Miyamoto, M
    Satoh, S
    Nakahira, S
    Tomono, T
    Murozuka, T
    Takeda, Y
    Doi, Y
    Mine, H
    Yokoyama, S
    Hirose, T
    Nishioka, K
    MICROBIOLOGY AND IMMUNOLOGY, 2001, 45 (09) : 667 - 672
  • [26] Evaluation of an individual-donation nucleic acid amplification testing algorithm for detecting hepatitis B virus infection in Chinese blood donors
    Gou, Hongna
    Pan, Yang
    Ge, Hongwei
    Zheng, Yourong
    Wu, Yaling
    Zeng, Jinfeng
    Yang, Zhongsi
    Pan, Tong
    Cun, Wei
    Zhou, Guoping
    Fang, Gen
    Zhang, Jiahong
    Zhang, Kuo
    Zhang, Rui
    Sun, Yu
    Xie, Jiehong
    Li, Jinming
    Wang, Lunan
    TRANSFUSION, 2015, 55 (09) : 2272 - 2281
  • [27] Transfusion-transmitted hepatitis B virus (HBV) infection from an individual-donation nucleic acid (ID-NAT) non-reactive donor
    O'Flaherty, N.
    Ushiro-Lumb, I.
    Pomeroy, L.
    Ijaz, S.
    Boland, F.
    De Gascun, C.
    Fitzgerald, J.
    O'Riordan, J.
    VOX SANGUINIS, 2018, 113 (03) : 300 - 303
  • [28] The art and science of reproductive donor screening: pooled testing (PT) vs. individual donor nucleic acid testing (ID NAT) and false positive test rate.
    Gorlin, J. B.
    Lanzen, M.
    VanHulzen, J.
    FERTILITY AND STERILITY, 2007, 88 : S26 - S26
  • [29] The first Indian multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus-1 ND hepatitis C and B viruses (HIV-1, HCV, HBV)
    不详
    VOX SANGUINIS, 2005, 89 : 9 - 10
  • [30] Excluding Occult Hepatitis B Infection before Assigning False-Positive Status to Non-Repeatable NAT Reactivity: Concerning Stolz et al. "Safe-Testing Algorithm for Individual-Donation Nucleic Acid Testing: 10 Years of Experience in a Low-Prevalence Country" [Transfus Med Hemother. 2019 Apr;46(2):104-10]
    Styles, Claire E.
    Cheng, Anthea
    Hoad, Veronica C.
    Kiely, Philip
    Watson, Michael
    Seed, Clive R.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2020, 47 (03) : 272 - 274
123